# Addressing Vaccine AcceptaNce in Carceral Settings through Community Engagement (ADVANCE)

> **NIH NIH R01** · YALE UNIVERSITY · 2022 · $665,807

## Abstract

PROJECT SUMMARY
The COVID-19 pandemic has had a disproportionate impact on those who are incarcerated and work in our
nation's prisons and jails. The prison population has had an infection rate that is five times the rate in the
general population and correctional staff have been infected at three times the rate of the general population.
High rates of COVID-19 in correctional systems are linked to high rates in surrounding communities, especially
in jails with high population turnover and in communities where correctional officers work. Vaccination in
correctional systems is an important community-wide COVID-19 mitigation strategy. But rates of vaccine
acceptance vary considerably, in part due to issues of distrust and unique social norms and policies within
correctional systems. Prior work on vaccine acceptance strategies, even amongst Black and Latinx people who
are disproportionately incarcerated, has rarely focused on strategies that work in corrections. Until this
knowledge gap is addressed, it will be difficult to reduce the disproportionate impact of COVID-19 on
minoritized populations in correctional facilities and the communities to which they return. This is especially
important with ongoing new variants emerging. The overall objective of this proposal, ADdressing Vaccine
AcceptaNce in Carceral Settings through Community Engagement (ADVANCE), is to identify feasible and
effective interventions to improve vaccine uptake in prisons. We will adapt the successful P3 vaccine
acceptance model for healthcare practices, developed by our team, to identify new and iterate on old strategies
appropriate for prisons, creating a new Patient, Provider, Practice, Prison-level (P4) framework. The central
hypothesis of the proposal is that strategies developed by and studied in partnership with people directly
impacted by the correctional system will increase vaccine acceptance. To test this hypothesis, we will tackle
three aims: (1) identify promising correctional system-based strategies to improve vaccine acceptance; (2)
adapt these strategies into an updated P4 framework using community based participatory research approach;
and (3) study the effectiveness of these interventions through rapid cycle, cluster-randomized trials in the
Pennsylvania correctional system. Throughout study phases, currently and previously incarcerated people and
correctional staff will provide input so P4 interventions are most likely to succeed. ADVANCE represents a
substantial departure from previous work on vaccine acceptance by focusing on providing an evidence base
for addressing vaccine acceptance in correctional systems that can be scaled and adapted for other justice-
involved populations.

## Key facts

- **NIH application ID:** 10585239
- **Project number:** 1R01MD016853-01A1
- **Recipient organization:** YALE UNIVERSITY
- **Principal Investigator:** DEANNA HOSKINS
- **Activity code:** R01 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2022
- **Award amount:** $665,807
- **Award type:** 1
- **Project period:** 2022-09-26 → 2026-06-30

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10585239

## Citation

> US National Institutes of Health, RePORTER application 10585239, Addressing Vaccine AcceptaNce in Carceral Settings through Community Engagement (ADVANCE) (1R01MD016853-01A1). Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/grant/nih/10585239. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*